HNMPA

CAS No. 132541-52-7

HNMPA( —— )

Catalog No. M27459 CAS No. 132541-52-7

HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 103 In Stock
2MG 56 In Stock
5MG 81 In Stock
10MG 140 In Stock
25MG 301 In Stock
50MG 442 In Stock
100MG 646 In Stock
200MG Get Quote In Stock
500MG 1367 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HNMPA
  • Note
    Research use only, not for human use.
  • Brief Description
    HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.
  • Description
    HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.(In Vitro):HNMPA reduces neuronal firing after GABA application and blocks GABA-dependent insulin inhibition. HNMPA has no effect on cyclic AMP-dependent protein kinase or protein kinase C activities.
  • In Vitro
    HNMPA inhibits the phosphorylation of a synthetic peptide substrate composed of insulin receptor residues 1290-1319 on serines-1305/1306 by partially purified insulin receptors.HNMPA blocks GABA-dependent insulin inhibition, and reduces neuronal firing after GABA application.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    DNMT3B|Parasite|antimalarial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132541-52-7
  • Formula Weight
    238.18
  • Molecular Formula
    C11H11O4P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=P(O)(O)C(O)C=1C=CC=2C=CC=CC2C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tanaka Y, et al.Heme-dependent radical generation: possible involvement in antimalarial action of non-peroxide microbial metabolites, nanaomycin A and radicicol.J Antibiot (Tokyo). 1999 Oct;52(10):880-8.
molnova catalog
related products
  • NBI-31772

    NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.

  • NVP-ADW742

    NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM.

  • Linsitinib

    Linsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.